Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease
Identifieur interne : 003279 ( Main/Curation ); précédent : 003278; suivant : 003280Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease
Auteurs : Olivier Guillin [France] ; Nathalie Griffon [France] ; Erwan Bezard [France] ; Ludovic Leriche [France] ; Jorge Diaz [France] ; Christian Gross [France] ; Pierre Sokoloff [France]Source :
- European journal of pharmacology [ 0014-2999 ] ; 2003.
Descripteurs français
- Pascal (Inist)
English descriptors
- KwdEn :
- Animals, Behavior, Brain derived neurotrophic factor, Brain-Derived Neurotrophic Factor (genetics), Brain-Derived Neurotrophic Factor (physiology), Brain-Derived Neurotrophic Factor (therapeutic use), D3 Dopamine receptor, Dopamine, Dopamine Agonists (pharmacology), Dopamine Agonists (therapeutic use), Dyskinesia, Gene Expression Regulation (drug effects), Humans, Parkinson Disease (drug therapy), Parkinson Disease (genetics), Parkinson Disease (metabolism), Parkinson disease, Protein Binding (drug effects), Protein Binding (physiology), Receptors, Dopamine D2 (agonists), Receptors, Dopamine D2 (biosynthesis), Receptors, Dopamine D2 (genetics), Receptors, Dopamine D3, Sensitization.
- MESH :
- chemical , agonists : Receptors, Dopamine D2.
- chemical , biosynthesis : Receptors, Dopamine D2.
- chemical , genetics : Brain-Derived Neurotrophic Factor, Receptors, Dopamine D2.
- chemical , pharmacology : Dopamine Agonists.
- chemical , physiology : Brain-Derived Neurotrophic Factor.
- chemical , therapeutic use : Brain-Derived Neurotrophic Factor, Dopamine Agonists.
- drug effects : Gene Expression Regulation, Protein Binding.
- drug therapy : Parkinson Disease.
- genetics : Parkinson Disease.
- metabolism : Parkinson Disease.
- physiology : Protein Binding.
- Animals, Humans, Receptors, Dopamine D3.
Abstract
Brain-derived neurotrophic factor (BDNF) belongs to a family of proteins related to nerve growth factor, which are responsible for neuron proliferation, survival and differentiation. A more diverse role for BDNF as a neuronal extracellular transmitter has, nevertheless, been proposed. Here we show that BDNF synthesized by dopamine neurons is responsible for the appearance of the dopamine D3 receptor during development and maintains its expression in adults. Moreover, BDNF triggers behavioral sensitization to levodopa in hemiparkinsonian rats. In monkeys rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which develop levodopa-induced dyskinesia, we show an overexpression of this receptor. Administration of a dopamine D3 receptor-selective partial agonist strongly attenuated levodopa-induced dyskinesia, while leaving unaffected the therapeutic effect of levodopa. These results suggest that the dopamine D3 receptor participates in both dyskinesia and the therapeutic action of levodopa and that partial agonists may normalize dopamine D3 receptor function and correct side-effects of levodopa therapy in PD patients.
Links toward previous steps (curation, corpus...)
- to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000D74
- to stream PascalFrancis, to step Curation: Pour aller vers cette notice dans l'étape Curation :000660
- to stream PascalFrancis, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000E04
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003767
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001068
- to stream PubMed, to step Curation: Pour aller vers cette notice dans l'étape Curation :001027
- to stream PubMed, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :001027
- to stream Ncbi, to step Merge: Pour aller vers cette notice dans l'étape Curation :000392
- to stream Ncbi, to step Curation: Pour aller vers cette notice dans l'étape Curation :000392
- to stream Ncbi, to step Checkpoint: Pour aller vers cette notice dans l'étape Curation :000392
- to stream Main, to step Merge: Pour aller vers cette notice dans l'étape Curation :003554
Links to Exploration step
Pascal:04-0477302Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease</title>
<author><name sortKey="Guillin, Olivier" sort="Guillin, Olivier" uniqKey="Guillin O" first="Olivier" last="Guillin">Olivier Guillin</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Griffon, Nathalie" sort="Griffon, Nathalie" uniqKey="Griffon N" first="Nathalie" last="Griffon">Nathalie Griffon</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UNIR 5543, Université Victor Segalen</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leriche, Ludovic" sort="Leriche, Ludovic" uniqKey="Leriche L" first="Ludovic" last="Leriche">Ludovic Leriche</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, Jorge" sort="Diaz, Jorge" uniqKey="Diaz J" first="Jorge" last="Diaz">Jorge Diaz</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Laboratoire de Physiologie, Université René Descartes, Avenue de l'Observatoire</s1>
<s2>75006 Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gross, Christian" sort="Gross, Christian" uniqKey="Gross C" first="Christian" last="Gross">Christian Gross</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UNIR 5543, Université Victor Segalen</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sokoloff, Pierre" sort="Sokoloff, Pierre" uniqKey="Sokoloff P" first="Pierre" last="Sokoloff">Pierre Sokoloff</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0477302</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 04-0477302 INIST</idno>
<idno type="RBID">Pascal:04-0477302</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D74</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000660</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000E04</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000E04</idno>
<idno type="wicri:doubleKey">0014-2999:2003:Guillin O:brain:derived:neurotrophic</idno>
<idno type="wicri:Area/Main/Merge">003767</idno>
<idno type="wicri:source">PubMed</idno>
<idno type="RBID">pubmed:14623353</idno>
<idno type="wicri:Area/PubMed/Corpus">001068</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001068</idno>
<idno type="wicri:Area/PubMed/Curation">001027</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001027</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001027</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001027</idno>
<idno type="wicri:Area/Ncbi/Merge">000392</idno>
<idno type="wicri:Area/Ncbi/Curation">000392</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000392</idno>
<idno type="wicri:doubleKey">0014-2999:2003:Guillin O:brain:derived:neurotrophic</idno>
<idno type="wicri:Area/Main/Merge">003554</idno>
<idno type="wicri:Area/Main/Curation">003279</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease</title>
<author><name sortKey="Guillin, Olivier" sort="Guillin, Olivier" uniqKey="Guillin O" first="Olivier" last="Guillin">Olivier Guillin</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Griffon, Nathalie" sort="Griffon, Nathalie" uniqKey="Griffon N" first="Nathalie" last="Griffon">Nathalie Griffon</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UNIR 5543, Université Victor Segalen</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leriche, Ludovic" sort="Leriche, Ludovic" uniqKey="Leriche L" first="Ludovic" last="Leriche">Ludovic Leriche</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, Jorge" sort="Diaz, Jorge" uniqKey="Diaz J" first="Jorge" last="Diaz">Jorge Diaz</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Laboratoire de Physiologie, Université René Descartes, Avenue de l'Observatoire</s1>
<s2>75006 Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gross, Christian" sort="Gross, Christian" uniqKey="Gross C" first="Christian" last="Gross">Christian Gross</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UNIR 5543, Université Victor Segalen</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sokoloff, Pierre" sort="Sokoloff, Pierre" uniqKey="Sokoloff P" first="Pierre" last="Sokoloff">Pierre Sokoloff</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">European journal of pharmacology</title>
<title level="j" type="abbreviated">Eur. j. pharmacol.</title>
<idno type="ISSN">0014-2999</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">European journal of pharmacology</title>
<title level="j" type="abbreviated">Eur. j. pharmacol.</title>
<idno type="ISSN">0014-2999</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Behavior</term>
<term>Brain derived neurotrophic factor</term>
<term>Brain-Derived Neurotrophic Factor (genetics)</term>
<term>Brain-Derived Neurotrophic Factor (physiology)</term>
<term>Brain-Derived Neurotrophic Factor (therapeutic use)</term>
<term>D3 Dopamine receptor</term>
<term>Dopamine</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Dyskinesia</term>
<term>Gene Expression Regulation (drug effects)</term>
<term>Humans</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Parkinson disease</term>
<term>Protein Binding (drug effects)</term>
<term>Protein Binding (physiology)</term>
<term>Receptors, Dopamine D2 (agonists)</term>
<term>Receptors, Dopamine D2 (biosynthesis)</term>
<term>Receptors, Dopamine D2 (genetics)</term>
<term>Receptors, Dopamine D3</term>
<term>Sensitization</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="agonists" xml:lang="en"><term>Receptors, Dopamine D2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Receptors, Dopamine D2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Brain-Derived Neurotrophic Factor</term>
<term>Receptors, Dopamine D2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Dopamine Agonists</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Brain-Derived Neurotrophic Factor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Brain-Derived Neurotrophic Factor</term>
<term>Dopamine Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Gene Expression Regulation</term>
<term>Protein Binding</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Protein Binding</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Humans</term>
<term>Receptors, Dopamine D3</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Facteur BDNF</term>
<term>Récepteur dopaminergique D3</term>
<term>Parkinson maladie</term>
<term>Dopamine</term>
<term>Comportement</term>
<term>Sensibilisation</term>
<term>Dyskinésie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Brain-derived neurotrophic factor (BDNF) belongs to a family of proteins related to nerve growth factor, which are responsible for neuron proliferation, survival and differentiation. A more diverse role for BDNF as a neuronal extracellular transmitter has, nevertheless, been proposed. Here we show that BDNF synthesized by dopamine neurons is responsible for the appearance of the dopamine D3 receptor during development and maintains its expression in adults. Moreover, BDNF triggers behavioral sensitization to levodopa in hemiparkinsonian rats. In monkeys rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which develop levodopa-induced dyskinesia, we show an overexpression of this receptor. Administration of a dopamine D3 receptor-selective partial agonist strongly attenuated levodopa-induced dyskinesia, while leaving unaffected the therapeutic effect of levodopa. These results suggest that the dopamine D3 receptor participates in both dyskinesia and the therapeutic action of levodopa and that partial agonists may normalize dopamine D3 receptor function and correct side-effects of levodopa therapy in PD patients.</div>
</front>
</TEI>
<double idat="0014-2999:2003:Guillin O:brain:derived:neurotrophic"><INIST><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease</title>
<author><name sortKey="Guillin, Olivier" sort="Guillin, Olivier" uniqKey="Guillin O" first="Olivier" last="Guillin">Olivier Guillin</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Griffon, Nathalie" sort="Griffon, Nathalie" uniqKey="Griffon N" first="Nathalie" last="Griffon">Nathalie Griffon</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UNIR 5543, Université Victor Segalen</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leriche, Ludovic" sort="Leriche, Ludovic" uniqKey="Leriche L" first="Ludovic" last="Leriche">Ludovic Leriche</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, Jorge" sort="Diaz, Jorge" uniqKey="Diaz J" first="Jorge" last="Diaz">Jorge Diaz</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Laboratoire de Physiologie, Université René Descartes, Avenue de l'Observatoire</s1>
<s2>75006 Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gross, Christian" sort="Gross, Christian" uniqKey="Gross C" first="Christian" last="Gross">Christian Gross</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UNIR 5543, Université Victor Segalen</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sokoloff, Pierre" sort="Sokoloff, Pierre" uniqKey="Sokoloff P" first="Pierre" last="Sokoloff">Pierre Sokoloff</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">04-0477302</idno>
<date when="2003">2003</date>
<idno type="stanalyst">PASCAL 04-0477302 INIST</idno>
<idno type="RBID">Pascal:04-0477302</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000D74</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000660</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000E04</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000E04</idno>
<idno type="wicri:doubleKey">0014-2999:2003:Guillin O:brain:derived:neurotrophic</idno>
<idno type="wicri:Area/Main/Merge">003767</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease</title>
<author><name sortKey="Guillin, Olivier" sort="Guillin, Olivier" uniqKey="Guillin O" first="Olivier" last="Guillin">Olivier Guillin</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Griffon, Nathalie" sort="Griffon, Nathalie" uniqKey="Griffon N" first="Nathalie" last="Griffon">Nathalie Griffon</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UNIR 5543, Université Victor Segalen</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Leriche, Ludovic" sort="Leriche, Ludovic" uniqKey="Leriche L" first="Ludovic" last="Leriche">Ludovic Leriche</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Diaz, Jorge" sort="Diaz, Jorge" uniqKey="Diaz J" first="Jorge" last="Diaz">Jorge Diaz</name>
<affiliation wicri:level="3"><inist:fA14 i1="03"><s1>Laboratoire de Physiologie, Université René Descartes, Avenue de l'Observatoire</s1>
<s2>75006 Paris</s2>
<s3>FRA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gross, Christian" sort="Gross, Christian" uniqKey="Gross C" first="Christian" last="Gross">Christian Gross</name>
<affiliation wicri:level="3"><inist:fA14 i1="02"><s1>Basal Gang, Laboratoire de Neurophysiologie, CNRS UNIR 5543, Université Victor Segalen</s1>
<s2>33076 Bordeaux</s2>
<s3>FRA</s3>
<sZ>3 aut.</sZ>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Nouvelle-Aquitaine</region>
<region type="old region" nuts="2">Aquitaine</region>
<settlement type="city">Bordeaux</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Sokoloff, Pierre" sort="Sokoloff, Pierre" uniqKey="Sokoloff P" first="Pierre" last="Sokoloff">Pierre Sokoloff</name>
<affiliation wicri:level="3"><inist:fA14 i1="01"><s1>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia</s1>
<s2>75014 Paris</s2>
<s3>FRA</s3>
<sZ>1 aut.</sZ>
<sZ>2 aut.</sZ>
<sZ>4 aut.</sZ>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>France</country>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">European journal of pharmacology</title>
<title level="j" type="abbreviated">Eur. j. pharmacol.</title>
<idno type="ISSN">0014-2999</idno>
<imprint><date when="2003">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">European journal of pharmacology</title>
<title level="j" type="abbreviated">Eur. j. pharmacol.</title>
<idno type="ISSN">0014-2999</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Behavior</term>
<term>Brain derived neurotrophic factor</term>
<term>D3 Dopamine receptor</term>
<term>Dopamine</term>
<term>Dyskinesia</term>
<term>Parkinson disease</term>
<term>Sensitization</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Facteur BDNF</term>
<term>Récepteur dopaminergique D3</term>
<term>Parkinson maladie</term>
<term>Dopamine</term>
<term>Comportement</term>
<term>Sensibilisation</term>
<term>Dyskinésie</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Brain-derived neurotrophic factor (BDNF) belongs to a family of proteins related to nerve growth factor, which are responsible for neuron proliferation, survival and differentiation. A more diverse role for BDNF as a neuronal extracellular transmitter has, nevertheless, been proposed. Here we show that BDNF synthesized by dopamine neurons is responsible for the appearance of the dopamine D3 receptor during development and maintains its expression in adults. Moreover, BDNF triggers behavioral sensitization to levodopa in hemiparkinsonian rats. In monkeys rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which develop levodopa-induced dyskinesia, we show an overexpression of this receptor. Administration of a dopamine D3 receptor-selective partial agonist strongly attenuated levodopa-induced dyskinesia, while leaving unaffected the therapeutic effect of levodopa. These results suggest that the dopamine D3 receptor participates in both dyskinesia and the therapeutic action of levodopa and that partial agonists may normalize dopamine D3 receptor function and correct side-effects of levodopa therapy in PD patients.</div>
</front>
</TEI>
</INIST>
<PubMed><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease.</title>
<author><name sortKey="Guillin, Olivier" sort="Guillin, Olivier" uniqKey="Guillin O" first="Olivier" last="Guillin">Olivier Guillin</name>
<affiliation wicri:level="3"><nlm:affiliation>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia, 75014, Paris, France. olivierguillin@yahoo.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia, 75014, Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Griffon, Nathalie" sort="Griffon, Nathalie" uniqKey="Griffon N" first="Nathalie" last="Griffon">Nathalie Griffon</name>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
</author>
<author><name sortKey="Leriche, Ludovic" sort="Leriche, Ludovic" uniqKey="Leriche L" first="Ludovic" last="Leriche">Ludovic Leriche</name>
</author>
<author><name sortKey="Diaz, Jorge" sort="Diaz, Jorge" uniqKey="Diaz J" first="Jorge" last="Diaz">Jorge Diaz</name>
</author>
<author><name sortKey="Gross, Christian" sort="Gross, Christian" uniqKey="Gross C" first="Christian" last="Gross">Christian Gross</name>
</author>
<author><name sortKey="Sokoloff, Pierre" sort="Sokoloff, Pierre" uniqKey="Sokoloff P" first="Pierre" last="Sokoloff">Pierre Sokoloff</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2003">2003</date>
<idno type="RBID">pubmed:14623353</idno>
<idno type="pmid">14623353</idno>
<idno type="wicri:Area/PubMed/Corpus">001068</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001068</idno>
<idno type="wicri:Area/PubMed/Curation">001027</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001027</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001027</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001027</idno>
<idno type="wicri:Area/Ncbi/Merge">000392</idno>
<idno type="wicri:Area/Ncbi/Curation">000392</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000392</idno>
<idno type="wicri:doubleKey">0014-2999:2003:Guillin O:brain:derived:neurotrophic</idno>
<idno type="wicri:Area/Main/Merge">003554</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease.</title>
<author><name sortKey="Guillin, Olivier" sort="Guillin, Olivier" uniqKey="Guillin O" first="Olivier" last="Guillin">Olivier Guillin</name>
<affiliation wicri:level="3"><nlm:affiliation>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia, 75014, Paris, France. olivierguillin@yahoo.fr</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Unité de Neurobiologie et Pharmacologie Moléculaire, INSERM U 573, Centre Paul Broca, 2 ter rue d'Alésia, 75014, Paris</wicri:regionArea>
<placeName><region type="region" nuts="2">Île-de-France</region>
<settlement type="city">Paris</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Griffon, Nathalie" sort="Griffon, Nathalie" uniqKey="Griffon N" first="Nathalie" last="Griffon">Nathalie Griffon</name>
</author>
<author><name sortKey="Bezard, Erwan" sort="Bezard, Erwan" uniqKey="Bezard E" first="Erwan" last="Bezard">Erwan Bezard</name>
</author>
<author><name sortKey="Leriche, Ludovic" sort="Leriche, Ludovic" uniqKey="Leriche L" first="Ludovic" last="Leriche">Ludovic Leriche</name>
</author>
<author><name sortKey="Diaz, Jorge" sort="Diaz, Jorge" uniqKey="Diaz J" first="Jorge" last="Diaz">Jorge Diaz</name>
</author>
<author><name sortKey="Gross, Christian" sort="Gross, Christian" uniqKey="Gross C" first="Christian" last="Gross">Christian Gross</name>
</author>
<author><name sortKey="Sokoloff, Pierre" sort="Sokoloff, Pierre" uniqKey="Sokoloff P" first="Pierre" last="Sokoloff">Pierre Sokoloff</name>
</author>
</analytic>
<series><title level="j">European journal of pharmacology</title>
<idno type="ISSN">0014-2999</idno>
<imprint><date when="2003" type="published">2003</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Animals</term>
<term>Brain-Derived Neurotrophic Factor (genetics)</term>
<term>Brain-Derived Neurotrophic Factor (physiology)</term>
<term>Brain-Derived Neurotrophic Factor (therapeutic use)</term>
<term>Dopamine Agonists (pharmacology)</term>
<term>Dopamine Agonists (therapeutic use)</term>
<term>Gene Expression Regulation (drug effects)</term>
<term>Humans</term>
<term>Parkinson Disease (drug therapy)</term>
<term>Parkinson Disease (genetics)</term>
<term>Parkinson Disease (metabolism)</term>
<term>Protein Binding (drug effects)</term>
<term>Protein Binding (physiology)</term>
<term>Receptors, Dopamine D2 (agonists)</term>
<term>Receptors, Dopamine D2 (biosynthesis)</term>
<term>Receptors, Dopamine D2 (genetics)</term>
<term>Receptors, Dopamine D3</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="agonists" xml:lang="en"><term>Receptors, Dopamine D2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="biosynthesis" xml:lang="en"><term>Receptors, Dopamine D2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Brain-Derived Neurotrophic Factor</term>
<term>Receptors, Dopamine D2</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Dopamine Agonists</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="physiology" xml:lang="en"><term>Brain-Derived Neurotrophic Factor</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Brain-Derived Neurotrophic Factor</term>
<term>Dopamine Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>Gene Expression Regulation</term>
<term>Protein Binding</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en"><term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Protein Binding</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Animals</term>
<term>Humans</term>
<term>Receptors, Dopamine D3</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Brain-derived neurotrophic factor (BDNF) belongs to a family of proteins related to nerve growth factor, which are responsible for neuron proliferation, survival and differentiation. A more diverse role for BDNF as a neuronal extracellular transmitter has, nevertheless, been proposed. Here we show that BDNF synthesized by dopamine neurons is responsible for the appearance of the dopamine D3 receptor during development and maintains its expression in adults. Moreover, BDNF triggers behavioral sensitization to levodopa in hemiparkinsonian rats. In monkeys rendered parkinsonian with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which develop levodopa-induced dyskinesia, we show an overexpression of this receptor. Administration of a dopamine D3 receptor-selective partial agonist strongly attenuated levodopa-induced dyskinesia, while leaving unaffected the therapeutic effect of levodopa. These results suggest that the dopamine D3 receptor participates in both dyskinesia and the therapeutic action of levodopa and that partial agonists may normalize dopamine D3 receptor function and correct side-effects of levodopa therapy in PD patients.</div>
</front>
</TEI>
</PubMed>
</double>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003279 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 003279 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= ParkinsonFranceV1 |flux= Main |étape= Curation |type= RBID |clé= Pascal:04-0477302 |texte= Brain-derived neurotrophic factor controls dopamine D3 receptor expression: therapeutic implications in Parkinson's disease }}
![]() | This area was generated with Dilib version V0.6.29. | ![]() |